Use your browser's back button to choose another title or click here for a New Search.

How to Get the Presentation

 Open PDF


Bookmark and Share

Motivational Enhancement Therapy for Pregnant Substance Users: Results from the NIDA CTN Trial.

Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.

Theresa M. Winhusen, PhD (University of Cincinnati/CinARC, OV Node).

This presentation describes protocol CTN-0013, "Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users," which aimed to improve treatment retention for pregnant substance users. Two hundred pregnant substance users entering outpatient substance abuse treatment at one of the four participating CTPs (community treatment programs) were randomized to receive either three individual sessions of Motivational Enhancement Therapy for pregnant substance users (MET-PS) or the first three individual sessions normally provided by the program. Study investigators found that MET was not more effective in increasing treatment utilization or decreasing substance use in the sample as a whole. However, various factors may have contributed to this finding, including one participating CTP's modifications of its "treatment as usual" procedures, and issues with sample size. (Presentation, PDF, English, 2008)

Keywords: Behavior therapy | Gender-specific interventions | Motivational Enhancement Therapy (MET) | Motivational interviewing (MI) | Pregnant women | Retention - Treatment | Women | NIDA Blending Conference, 2008

Document No: 282

Submitted by CTN Dissemination Librarians (6/16/2008).

Winhusen, Theresa M. search mail
NIDA-CTN-0013 search www
Ohio Valley (Lead) search www
North Carolina search www
Southwest search www

dark blue line
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 8/2009 --
dark blue line